| Filed On | Filing |
|---|---|
| 15 Oct 2026 | MA-I/A |
| 01 Oct 2026 | MA/A |
| 23 Sep 2026 | MA-I/A |
| 09 Sep 2026 | MA-I |
| 01 Sep 2026 | MA-I |
| 31 Aug 2026 | MA-I |
| 31 Aug 2026 | MA-I |
| 31 Aug 2026 | MA-I |
| 31 Aug 2026 | MA-I |
| 28 Aug 2026 |
Form 4/A: Goldman Sachs Group Inc, Former 10% Owner and 7 others · Attovia Therapeutics Inc
Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Acquired 105,807 Equity Swap (Open Market Purchase) ($2.25M) · 2 more |
| 28 Aug 2026 | MA-I/A |
| 17 Aug 2026 | N-PX |
| 14 Aug 2026 | 13F-NT |
| 13 Aug 2026 |
Form 4: Goldman Sachs Group Inc, Former 10% Owner and 7 others · Attovia Therapeutics Inc
Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Received 2,435,632 shares by conversion · 1 more |
| 10 Aug 2026 | Form 4: Goldman Sachs Group Inc, 10% owner and 1 other · Old QVC Group, Inc. |
| 04 Aug 2026 | Form 3: Goldman Sachs Group Inc, 10% owner and 7 others · Attovia Therapeutics Inc |
| 04 Aug 2026 | MA-I/A |
| 31 Jul 2026 | MA-I/A |
| 27 Jul 2026 | MA/A |
| 27 Jul 2026 | MA-I |
Loading...